Jane Street Group LLC Sells 7,072 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Jane Street Group LLC lowered its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 13.9% in the third quarter, Holdings Channel reports. The institutional investor owned 43,847 shares of the company’s stock after selling 7,072 shares during the period. Jane Street Group LLC’s holdings in Phibro Animal Health were worth $987,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Quantbot Technologies LP acquired a new position in Phibro Animal Health in the 3rd quarter valued at approximately $70,000. nVerses Capital LLC acquired a new stake in shares of Phibro Animal Health during the 3rd quarter worth approximately $70,000. China Universal Asset Management Co. Ltd. increased its position in shares of Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the period. CWM LLC raised its stake in shares of Phibro Animal Health by 190.8% in the third quarter. CWM LLC now owns 6,363 shares of the company’s stock valued at $143,000 after purchasing an additional 4,175 shares in the last quarter. Finally, Algert Global LLC bought a new position in Phibro Animal Health in the second quarter worth $193,000. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Stock Up 0.1 %

PAHC opened at $21.00 on Wednesday. The firm has a market cap of $850.56 million, a price-to-earnings ratio of 48.84, a PEG ratio of 0.58 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. The firm’s 50-day simple moving average is $23.17 and its 200-day simple moving average is $20.94. Phibro Animal Health Co. has a twelve month low of $10.03 and a twelve month high of $25.98.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.29%. Phibro Animal Health’s dividend payout ratio is 111.63%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on PAHC. Barclays increased their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target for the company. StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Friday, December 27th. Finally, Morgan Stanley upped their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.